# Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate

> **NCT01569451** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 53 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Glatiramer Acetate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01569451
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2018-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01569451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01569451, "Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01569451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*